Health TrialsbyHealthPanel

Mid- and Long-term Outcomes of Custom-made Aortic Devices

ConditionsAortic DiseasesThoracic Aortic Aneurysm
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

This study aims to evaluate mid- and long-term outcomes after Thoracic endovascular aortic repair (TEVAR) with custom-made devices.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Thoracic Aortic Disease

Disqualifiers

Urgent/Emergent treatment

Trial population

All the patients that underwent Thoracic Endovascular Aortic Repair (TEVAR) in the period 2015-2023 with the Custom Relay® Multi-Feature™ Terumo Aortic will be included in the analysis.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Thoracic endovascular aortic repair (TEVAR)

    Device

    The TEVAR procedure involves the placement of a covered stent (a metal mesh tube with a layer of fabric) into the weakened area of the artery.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Overall Mortality

Any death occurring during follow-up

Time frame
3 years
2

Aortic-related mortality

Any death occurring during follow-up and related to the procedure

Time frame
3 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead sponsor

Source ClinicalTrials.gov
Apply now